Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups

BACKGROUND: Tumour classification, based on histopathology or molecular pathology, is of value to predict tumour behaviour and to select appropriate treatment. In retinoblastoma, pathology information is not available at diagnosis and only exists for enucleated tumours. Alternative methods of tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohe, Sarah, Brundler, Marie-Anne, Jenkinson, Helen, Parulekar, Manoj, Wilson, Martin, Peet, Andrew C, McConville, Carmel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647873/
https://www.ncbi.nlm.nih.gov/pubmed/26348444
http://dx.doi.org/10.1038/bjc.2015.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647873/
https://www.ncbi.nlm.nih.gov/pubmed/26348444
http://dx.doi.org/10.1038/bjc.2015.318

Ejemplares similares